NZ Haematology Research Review Issue 7

In this issue:

Moderate PE treated with thrombolysis
VTE guidelines for cancer patients
Rivaroxaban for thromboprophylaxis in acutely ill medical patients
Characteristics of antibody responses against FVIII
Cardiovascular events and treatment intensity in polycythaemia vera
Apixaban for extended VTE treatment
Apixaban vs. warfarin for atrial fibrillation according to stroke/bleeding risk
Prognostic thrombosis model for essential thrombocythaemia
ADAMTS13 protects against myocardial ischaemia/reperfusion injury
Repeated short-term eltrombopag in chronic immune ITP

Please login below to download this issue (PDF)

Subscribe